On the subject of screening, an article in JAMA concludes ‘that annual screening for ovarian cancer as performed in the PLCO trial with simultaneous CA125 and transvaginal ultrasound does not reduce disease specific mortality in women at average risk for ovarian cancer but does increase invasive medical procedures and associated harms’. Effect of screening on Ovarian Cancer Mortality – The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomised Controlled Trial.
Saundra S Buys et al.JAMA.2011;305(22): 2295-2303
And on screening and over diagnosis, a commentary in Archives of Internal Medicine discusses the increasingly common phenomenon of pseudodisease Pseudodisease, the Next Great Epidemic in Coronary Atherosclerosis? Michael S. Lauer, MD Arch Intern Med. Published online May 23, 2011. doi:10.1001/archinternmed.2011.205 – a condition that would never have become clinically significant if it hadn’t been detected by a screening test. Pseudodisease can regress spontaneously, remain permanently subclinical, or progress so slowly that another disease kills the patient first. In any case, the patient derives no benefit from the diagnosis.

About bmitzi

Medical writer, author, artist. Cancer campaigner. Aiming always to improve health services and bring compassion into health care.
This entry was posted in Breast Cancer, Screening Mammography, Womb cancer and hysterectomy and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s